These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 11851748)

  • 21. Current evidence for the use of botulinum toxin type A in the management of children with cerebral palsy: a systematic review.
    Boyd RN; Hays RM
    Eur J Neurol; 2001 Nov; 8 Suppl 5():1-20. PubMed ID: 11851730
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pedobarometric evaluation of equinus foot disorder after injection of botulinum toxin A in children with cerebral palsy: a pilot study.
    Falso M; Fiaschi A; Manganotti P
    Dev Med Child Neurol; 2005 Jun; 47(6):396-402. PubMed ID: 15934488
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized study of combined botulinum toxin type A and casting in the ambulant child with cerebral palsy using objective outcome measures.
    Desloovere K; Molenaers G; Jonkers I; De Cat J; De Borre L; Nijs J; Eyssen M; Pauwels P; De Cock P
    Eur J Neurol; 2001 Nov; 8 Suppl 5():75-87. PubMed ID: 11851736
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Botulinum toxin type A in the treatment of lower limb spasticity in cerebral palsy.
    Ade-Hall RA; Moore AP
    Cochrane Database Syst Rev; 2000; (2):CD001408. PubMed ID: 10796784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of Botulinum Toxin on Equinus Foot Deformity in Cerebral Palsy Patients: A Systematic Review and Network Meta-analysis.
    Fathi M; Hussein AS; M Elghazaly S; Al-Kinawy AM; Abdeltawab AK; Mansour YM; Elbehbeh NA; Sherif A; Afifi AM
    Curr Pharm Des; 2020; 26(37):4796-4807. PubMed ID: 32418518
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of botulinum toxin therapy of spastic equinus in paediatric patients with cerebral palsy.
    Manganotti P; Zaina F; Falso M; Milanese F; Fiaschi A
    J Rehabil Med; 2007 Mar; 39(2):115-20. PubMed ID: 17351692
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Value of botulinum toxin injections preceding a comprehensive rehabilitation period for children with spastic cerebral palsy: A cost-effectiveness study.
    Schasfoort F; Dallmeijer A; Pangalila R; Catsman C; Stam H; Becher J; Steyerberg E; Polinder S; Bussmann J
    J Rehabil Med; 2018 Jan; 50(1):22-29. PubMed ID: 28949368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost-minimization analysis in the treatment of spasticity in children with cerebral palsy with botulinum toxin type A: an observational, longitudinal, retrospective study.
    Tapias G; García-Romero M; Crespo C; Cuesta M; Forné C; Pascual-Pascual SI
    Farm Hosp; 2016 Sep; 40(5):412-26. PubMed ID: 27570991
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Botulinum toxin and short-term electrical stimulation in the treatment of equinus in cerebral palsy.
    Detrembleur C; Lejeune TM; Renders A; Van Den Bergh PY
    Mov Disord; 2002 Jan; 17(1):162-9. PubMed ID: 11835456
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Costs and consequences of botulinum toxin type A use. Management of children with cerebral palsy in Germany.
    Ruiz FJ; Guest JF; Lehmann A; Davie AM; Güttler K; Schlüter O; Dreiss G
    Eur J Health Econ; 2004 Oct; 5(3):227-35. PubMed ID: 15714343
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuronox versus BOTOX for spastic equinus gait in children with cerebral palsy: a randomized, double-blinded, controlled multicentre clinical trial.
    Kim K; Shin HI; Kwon BS; Kim SJ; Jung IY; Bang MS
    Dev Med Child Neurol; 2011 Mar; 53(3):239-44. PubMed ID: 21087238
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and Safety of Letibotulinum Toxin A for the Treatment of Dynamic Equinus Foot Deformity in Children with Cerebral Palsy: A Randomized Controlled Trial.
    Chang HJ; Hong BY; Lee SJ; Lee S; Park JH; Kwon JY
    Toxins (Basel); 2017 Aug; 9(8):. PubMed ID: 28820439
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Botulinum toxin: a new dimension for spasticity].
    Reichel G
    MMW Fortschr Med; 2007 May; 149 Suppl 2():65-9. PubMed ID: 17724971
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Injection frequency of botulinum toxin A for spastic equinus: a randomized clinical trial.
    Hastings-Ison T; Blackburn C; Rawicki B; Fahey M; Simpson P; Baker R; Graham K
    Dev Med Child Neurol; 2016 Jul; 58(7):750-7. PubMed ID: 26589633
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Botulinum toxin treatment of spastic equinus in cerebral palsy: a randomized trial comparing two injection sites.
    Sätilä H; Iisalo T; Pietikäinen T; Seppänen RL; Salo M; Koivikko M; Autti-Rämö I; Haataja R
    Am J Phys Med Rehabil; 2005 May; 84(5):355-65; quiz 366-7, 392. PubMed ID: 15829782
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Longitudinal assessment of gait quality in children with bilateral cerebral palsy following repeated lower limb intramuscular Botulinum toxin-A injections.
    Read FA; Boyd RN; Barber LA
    Res Dev Disabil; 2017 Sep; 68():35-41. PubMed ID: 28735160
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment with Botulinum toxin A in a total population of children with cerebral palsy - a retrospective cohort registry study.
    Franzén M; Hägglund G; Alriksson-Schmidt A
    BMC Musculoskelet Disord; 2017 Dec; 18(1):520. PubMed ID: 29228927
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
    Wissel J; Entner T
    Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Botulinum toxin a treatment in children with cerebral palsy: its effects on walking and energy expenditure.
    Balaban B; Tok F; Tan AK; Matthews DJ
    Am J Phys Med Rehabil; 2012 Jan; 91(1):53-64. PubMed ID: 22157436
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spread of botulinum neurotoxin type a at standard doses is inherent to the successful treatment of spastic equinus foot in cerebral palsy: short-term neurophysiological and clinical study.
    Frasson E; Dall'ora E; Bordignon M; Brigo F; Tocco P; Primon D; Didonè G; Vicentini S; Fiaschi A; Bertolasi L
    J Child Neurol; 2012 May; 27(5):587-93. PubMed ID: 22114218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.